載入...
Review of Immune-Related Adverse Events (irAEs) in Non-Small-Cell Lung Cancer (NSCLC)—Their Incidence, Management, Multiorgan irAEs, and Rechallenge
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced malignancies, including non-small cell lung cancer (NSCLC). These agents have improved clinical outcomes and have become quite an attractive alternative alone or combined with other treatments. Although ICIs are tolera...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
MDPI AG
2022-03-01
|
叢編: | Biomedicines |
主題: | |
在線閱讀: | https://www.mdpi.com/2227-9059/10/4/790 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|